BRIEF

on AMOEBA (EPA:ALMIB)

Amoéba and Koppert Expand Partnership Into European Orchards

Stock price chart of AMOEBA (EPA:ALMIB) showing fluctuations.

Amoéba and Koppert have announced an expansion of their partnership to include orchards across Europe. This move targets Europe's fourth-largest fungicide market, aiming to protect around 40% of cultivated acreage. The agreement supports Amoéba's goal of €40 million in revenue by 2030.

The collaboration between Amoéba, a greentech leader, and global crop protection specialist Koppert, now extends to 19 European countries. This expansion builds on previous agreements covering vineyards and vegetable crops. The partnership capitalizes on the AXPERA technology for orchards.

This initiative responds to European fruit growers' need for effective biocontrol solutions amid climate challenges and restricted use of conventional options. The expanded scope covers vital crops like apples and pears across 600,000 hectares.

Following promising trials in 2026, Koppert and Amoéba enter a pre-commercialization phase with plans for further tests in 2027, targeting a product launch in 2029 pending regulatory approvals.

R. P.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AMOEBA news